5 Key Takeaways
-
1
Progress in genomic medicine has been measured by technical achievements, but the journey for patients often begins after a diagnosis is made.
-
2
Families frequently face uncertainties and decisions after receiving a genetic diagnosis, highlighting the need for effective communication and support.
-
3
Laboratories focus on quality indicators like turnaround time and diagnostic yield, but these metrics do not assess patient understanding or follow-up.
-
4
As genomic medicine evolves, the challenge includes translating scientific advancements into meaningful care and informed decision-making for families.
-
5
Culturally sensitive education and accessible follow-up care are essential for effective genomic medicine, especially in regions with limited resources.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

About the Author(s)
Dina Abdelhakam
Dina Abdelhakam is Assistant Professor and Consultant Clinical Pathologist at Faculty of Medicine, Ain Shams University, Egypt